Brunaugh AD, Seo H, Warnken Z, Ding L, et al. Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae. PLoS One 2021;16:e0246803.
PMID: 33571320